首页> 外文期刊>Infection and immunity >Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.
【24h】

Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.

机译:通过使用从六个分离的蛋白质重构的替代补体途径,在封装的新型隐球菌上激活和结合C3的调理片段。

获取原文
           

摘要

Encapsulated Cryptococcus neoformans yeast cells are potent activators of the complement system. We examined the interaction of the yeast cells with an alternative complement pathway reconstituted from isolated factor D, factor B, factor H, factor I, C3, and properdin. Incubation of encapsulated cryptococci with the reconstituted pathway led to activation and binding of C3 fragments to the yeast cells that was quantitatively and qualitatively identical to that observed with normal human serum. Incubation with either normal serum or a mixture of isolated proteins led to binding of 4 x 10(7) to 5 x 10(7) C3 molecules to the yeast cells. The kinetics for activation and binding of C3 were identical, with maximum binding observed after a 20-min incubation. Immunoglobulin G was not needed for optimal activation kinetics. C3 fragments eluted from the yeast cells by treatment with hydroxylamine and subsequent analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis demonstrated the presence primarily of iC3b on yeast cells incubated with either normal serum or the reconstituted pathway. Ultrastructural examination of the opsonized yeast cells showed that the cryptococcal capsule was the site for binding of C3 activated from normal serum or the reconstituted pathway, with a dense accumulation of C3 at the periphery of the capsule. Thus, incubation of encapsulated cryptococci in the reconstituted pathway led to deposition of opsonic complement fragments at a site that was appropriate for interaction with phagocyte receptors. Cryptococci opsonized with the reconstituted pathway showed a markedly enhanced interaction with cultured human monocytes compared with unopsonized yeast cells, indicating that the alternative pathway alone is opsonic for yeast cells. However, the results indicate that additional serum factors are needed for optimal opsonization of yeast cells because a 35% reduction in the number of cryptococci bound to macrophages was observed with cryptococci opsonized with the reconstituted pathway compared with that observed when yeast cells were opsonized with normal serum.
机译:封装的新型隐球菌酵母细胞是补体系统的有效激活剂。我们检查了酵母细胞与从分离的因子D,因子B,因子H,因子I,C3和备解素重构的替代补体途径的相互作用。封装的隐球菌与重组途径的孵育导致C3片段与酵母细胞的活化和结合,其数量和质量与正常人血清中观察到的相同。与正常血清或分离蛋白的混合物一起孵育会导致4 x 10(7)到5 x 10(7)C3分子与酵母细胞结合。 C3活化和结合的动力学相同,孵育20分钟后观察到最大结合。最佳免疫动力学不需要免疫球蛋白G。通过用羟胺处理并随后通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分析从酵母细胞中洗脱的C3片段证明,iC3b主要存在于与正常血清或重组途径孵育的酵母细胞上。调理过的酵母细胞的超微结构检查显示,隐球菌胶囊是结合自正常血清或重组途径活化的C3的位点,在胶囊外围有C3的密集堆积。因此,在重构途径中包封的隐球菌的孵育导致调理性补体片段沉积在适合与吞噬细胞受体相互作用的位点。与未调理的酵母细胞相比,用重组途径调理的隐球菌显示与培养的人单核细胞的相互作用显着增强,表明单独的替代途径对酵母细胞是调理的。然而,结果表明,酵母细胞的最佳调理作用还需要其他血清因子,因为用重组途径调理的隐球菌与用正常调理酵母细胞调理的酵母相比,与巨噬细胞结合的隐球菌数量减少了35%。血清。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号